Li-Ping Jiang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Antiplatelet Therapy

Binding Protein

Induced Pluripotent Stem Cells

Top Venues

Biopharmaceutics & drug disposition

Molecular diagnosis & therapy

Xenobiotica; the fate of foreign compounds in biological systems

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Hong-Guang Xie, Li-Ping Jiang, Ting Tai, Jin-Zi Ji, Qiong-Yu Mi
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance. Molecular diagnosis & therapy 28 (2) (2024)
Hong-Guang Xie, Li-Ping Jiang, Ting Tai, Jin-Zi Ji, Qiong-Yu Mi
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance. Molecular diagnosis & therapy (2024)
Hong-Guang Xie, Li-Ping Jiang, Ting Tai, Jin-Zi Ji, Qiong-Yu Mi
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance. Molecular diagnosis & therapy 28 (2) (2024)
Xue-Mei Li, Hao-Dong Li, Yuan-Yuan Shao, Jin-Zi Ji, Ke Tang, Zhao-Dong Zheng, Yu Wu, Pei-Jie Ding, Jin Wang, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Min Fu, Hong-Guang Xie
The metabolic activation of and platelet response to vicagrel vary with P-glycoprotein deficiency, rather than P-glycoprotein inhibition, in mice. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Xue-Mei Li, Hao-Dong Li, Yuan-Yuan Shao, Jin-Zi Ji, Ke Tang, Zhao-Dong Zheng, Yu Wu, Pei-Jie Ding, Jin Wang, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Min Fu, Hong-Guang Xie
The metabolic activation of and platelet response to vicagrel vary with P-glycoprotein deficiency, rather than P-glycoprotein inhibition, in mice. Xenobiotica; the fate of foreign compounds in biological systems (2024)
Hong-Guang Xie, Li-Ping Jiang, Ting Tai, Jin-Zi Ji, Qiong-Yu Mi
The Complement System and C4b-Binding Protein: A Focus on the Promise of C4BPα as a Biomarker to Predict Clopidogrel Resistance. Molecular diagnosis & therapy 28 (2) (2024)
Ting Zhu, Yu Wu, Xue-Mei Li, Yu-Meng Jia, Huan Zhou, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Jin-Zi Ji, Hong-Guang Xie
Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine. Biopharmaceutics & drug disposition 43 (6) (2022)
Ting Zhu, Yu Wu, Xue-Mei Li, Yu-Meng Jia, Huan Zhou, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Jin-Zi Ji, Hong-Guang Xie
Vicagrel is hydrolyzed by Raf kinase inhibitor protein (RKIP) in human intestine. Biopharmaceutics & drug disposition (2022)
Ting Zhu, Yu Wu, Xue-Mei Li, Yu-Meng Jia, Huan Zhou, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Jin-Zi Ji, Hong-Guang Xie
Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine. Biopharmaceutics & drug disposition (2022)
Ting Zhu, Yu Wu, Xue-Mei Li, Yu-Meng Jia, Huan Zhou, Li-Ping Jiang, Ting Tai, Qiong-Yu Mi, Jin-Zi Ji, Hong-Guang Xie
Vicagrel is hydrolyzed by Raf kinase inhibitor protein in human intestine. Biopharmaceutics & drug disposition 43 (6) (2022)
Li-Ping Jiang, Jin-Zi Ji, Peng-Xin Ge, Ting Zhu, Qiong-Yu Mi, Ting Tai, Yi-Fei Li, Hong-Guang Xie
Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice. British journal of pharmacology (2021)